SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aayush Wellness hits upper circuit on the BSE

24 Sep 2025 Evaluate

Aayush Wellness is currently trading at upper limit of Rs. 74.11, up by 3.52 points or 4.99% from its previous closing of Rs. 70.59 on the BSE.

The scrip opened at Rs. 74.11 and has touched a high and low of Rs. 74.11 and Rs. 74.11 respectively. So far 37303 shares were traded on the counter.

The BSE group 'X' stock of face value Rs. 1 has touched a 52 week high of Rs. 267.30 on 18-Jul-2025 and a 52 week low of Rs. 42.48 on 24-Sep-2024.

Last one week high and low of the scrip stood at Rs. 74.11 and Rs. 55.51 respectively. The current market cap of the company is Rs. 360.71 crore.

The Non-Institutions held 100.00% stake in the company.

Aayush Wellness has entered into strategic collaboration with Healthrashi Nextgen India, under its recently launched Rs 50 million Startup Accelerator Program. This partnership marks Aayush Wellness’s expansion into India’s rapidly growing $370 billion healthcare market. 

As part of this Collaboration, Aayush Wellness will source medical equipment from Healthrashi Nextgen India including AI-enabled health kiosks, state-of-the-art mobile clinics, automated diagnostic platforms, and healthcare vending machines at Optimized cost. Aayush Wellness will harness this innovation under its own brand, leveraging its strong market presence to deliver affordable and accessible healthcare services at scale. 

By partnering with corporates, banks, residential societies, and educational institutions, it will provide on-ground health checkups directly to the masses. This approach addresses critical gaps in last-mile access where traditional healthcare often struggles to reach, while enabling scalable growth without significant capital expenditure.

Aayush Wellness is a pioneering name in health and wellness solutions, dedicated to offering products that merge wellbeing with innovation.

Aayush Wellness Share Price

35.23 -0.17 (-0.48%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 939.20
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×